跳转到主要内容


Meet with our product experts in one-on-one virtual sessions

Set Up a Meeting
快速连接

白皮书

Product Alert – Niraparib API

Product Alert – Niraparib API

Niraparib binds to the PARP enzyme and prevents it from repairing single-strand breaks in DNA. This causes the cancer cell's DNA to become more damaged, leading to cell death. Since cancer cells often have more DNA damage than healthy cells, they are more sensitive to the effects of PARP inhibitors like Niraparib.

Dr. Reddy's API Offering

  • Developing innovator Form (Tosylate monohydrate form 1), a gram sample can be offered.
  • Particle size distribution (PSD) - We can offer customized particle sizes based on customer requirements.
  • Reliable KSM suppliers added to ensure timely deliveries and adherence to stringent specifications.
  • Planning adequate capacity to supply development quantity in a short lead time.

To learn more about our API offerings, please read the Tech sheet on Niraparib API by filling out the contact form below.

Explore other Whitepapers:

Know More

Download Now

请填写下面的联系表以查看白皮书

给我们发电子邮件: api@drreddys.com | +91 40 49002222

免责声明

本目錄中的任何信息(包括對任何產品或服務的任何引用)均不構成銷售要約,或被解釋為代表銷售要約。受有效專利保護的產品不提供或供應用於商業用途。但是,只要存在此類監管豁免,就可以出於監管提交的目的提供此類產品的研究數量。買方應對各自市場的專利方案進行獨立評估,並承擔所有與專利相關的責任。在印度受有效專利保護的產品不可用於商業用途,但可用於第 107A 節。